Rasim Gucalp

Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon alfa-2b in advanced renal cell carcinoma.

Michael B. Atkins, Joseph A. Sparano, Richard I. Fisher et al. · Journal of Clinical Oncology · 1993 · 218 citations

Denosumab for Treatment of Hypercalcemia of Malignancy

Mimi I. Hu, Ilya Glezerman, Sophie Leboulleux et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 196 citations · Full text

Comparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemia.

Rasim Gucalp, Paul S. Ritch, P H Wiernik et al. · Journal of Clinical Oncology · 1992 · 151 citations

Sequential treatment with afatinib and osimertinib in patients with <i>EGFR</i> mutation-positive non-small-cell lung cancer: an observational study

Maximilian J. Hochmair, Alessandro Morabito, Desirée Hao et al. · Future Oncology · 2018 · 96 citations · Full text

Sequential Afatinib and Osimertinib in Patients with <i>EGFR</i> Mutation-Positive Non-Small-Cell Lung Cancer: Updated Analysis of the Observational Giotag Study

Maximilian J. Hochmair, Alessandro Morabito, Desirée Hao et al. · Future Oncology · 2019 · 82 citations · Full text